|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 78.00 EUR | +0.52% |
|
+2.09% | +4.14% |
| Apr. 28 | The bulls are hanging on! |  |
| Apr. 25 | The stock market returns to "Risk On" | |
| Capitalization | 920M 1.08B 857M 797M 1.47B 92.32B 1.64B 10.27B 3.93B 43.23B 4.04B 3.95B 159B | P/E ratio 2025 * |
15.4x | P/E ratio 2026 * | 15.3x |
|---|---|---|---|---|---|
| Enterprise value | 684M 800M 637M 593M 1.1B 68.65B 1.22B 7.64B 2.92B 32.14B 3B 2.94B 118B | EV / Sales 2025 * |
1.24x | EV / Sales 2026 * | 1.11x |
| Free-Float |
32.57% | Yield 2025 * |
1.23% | Yield 2026 * | 1.31% |
More valuation ratios
* Estimated data
More news
More press releases
More news
| 1 day | +0.52% | ||
| 1 week | +2.09% | ||
| Current month | +5.12% | ||
| 1 month | +7.00% | ||
| 3 months | +3.45% | ||
| 6 months | +4.28% | ||
| Current year | +4.14% |
| 1 week | 73.6 |  | 78 |
| 1 month | 68.7 | | 78 |
| Current year | 63.6 | | 85.6 |
| 1 year | 63.6 | | 102.8 |
| 3 years | 63.6 | | 128 |
| 5 years | 63.6 | | 161 |
| 10 years | 33.04 | | 161 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2010-09-21 | |
| Director of Finance/CFO | 60 | 2010-11-30 | |
Philippe Gruet
CTO | Chief Tech/Sci/R&D Officer | - | 2021-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Philippe Arnold
BRD | Director/Board Member | 84 | 2009-09-21 |
Étienne Frechin
CHM | Chairman | 87 | 1979-12-31 |
| Chairman | 56 | 2023-06-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.52% | +2.09% | -20.65% | -36.38% | 1.08B | ||
| -2.42% | -2.65% | -13.45% | -10.85% | 68.99B | ||
| -0.93% | +1.78% | +7.89% | -25.46% | 7.4B | ||
| +0.62% | +1.34% | -8.41% | +5.49% | 3.67B | ||
| -1.16% | +1.04% | -5.28% | -7.46% | 3.34B | ||
| -2.38% | -0.10% | +17.63% | -7.20% | 2.3B | ||
| -1.09% | +10.00% | +76.20% | +58.76% | 1.25B | ||
| +1.34% | -0.30% | +48.27% | +13.31% | 1.25B | ||
| +1.35% | +2.87% | +10.09% | -36.72% | 1.07B | ||
| -0.06% | -0.81% | +21.66% | -36.02% | 1.03B | ||
| Average | -0.42% | +1.32% | +13.40% | -8.25% | 9.14B | |
| Weighted average by Cap. | -1.96% | -1.64% | -7.78% | -10.77% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 553M 647M 515M 479M 886M 55.51B 984M 6.17B 2.36B 25.99B 2.43B 2.38B 95.33B | 572M 669M 533M 496M 916M 57.4B 1.02B 6.39B 2.44B 26.88B 2.51B 2.46B 98.59B |
| Net income | 60.93M 71.26M 56.75M 52.79M 97.54M 6.11B 108M 680M 260M 2.86B 267M 262M 10.5B | 59.77M 69.9M 55.67M 51.78M 95.68M 6B 106M 667M 255M 2.81B 262M 257M 10.3B |
| Net Debt | -236M -276M -220M -204M -378M -23.67B -420M -2.63B -1.01B -11.08B -1.03B -1.01B -40.65B | -287M -335M -267M -248M -459M -28.76B -510M -3.2B -1.22B -13.47B -1.26B -1.23B -49.39B |
More financial data
* Estimated data
Employees
2,469
Sector
Pharmaceuticals
Calendar
Sep. 10
- Q2 2025 Earnings Call
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-11 | 78.00 € | +0.52% | 2,381 |
| 25-07-10 | 77.60 € | +0.78% | 1,795 |
| 25-07-09 | 77.00 € | +2.67% | 3,613 |
| 25-07-08 | 75.00 € | +0.27% | 2,112 |
| 25-07-07 | 74.80 € | -2.09% | 1,343 |
Real-time Euronext Paris, July 11, 2025 at 11:55 am EDT
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
78.00EUR
Average target price
91.57EUR
Spread / Average Target
+17.40%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VETO Stock
Select your edition
All financial news and data tailored to specific country editions
